查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1825958

2025年3D细胞培养技术全球市场报告

3D Cell Culture Technologies Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，3D细胞培养技术的市场规模迅速扩张，从2024年的33.6亿美元成长到2025年的39.6亿美元，复合年增长率为17.9%。预测期内的成长归因于细胞生物学、药物研发的进步、慢性病盛行率的上升以及政府资金的投入。

预计未来几年，3D细胞培养技术市场规模将快速成长，到2029年将达到81.6亿美元，复合年增长率为19.8%。预测期内的成长可归因于製药业的发展、研发的不断加强以及环境和伦理方面的考量。预测期内的主要趋势包括个人化医疗、技术进步、生物列印和再生医学。

细胞培养是生产安全病毒疫苗的关键工序。 3D细胞培养是一种先进的体外技术，可使细胞在人工设计的环境中生长。

3D细胞培养技术主要分为基于支架的、无支架的和3D反应器。例如，3D反应器是一种专门用于3D细胞培养的塑胶圆柱形腔室。这些技术应用于癌症研究、干细胞研究、药物研发和再生医学等各个领域。其用户范围广泛，包括研究机构、生技公司、製药公司、医院和诊断中心。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗保健领域产生了重大影响，尤其是对基本医疗设备、诊断设备和药品的供应。医院和医疗机构正疲于应对进口手术器械、诊断影像系统以及注射器和导管等消耗品不断上涨的成本，而这些产品中的许多在国内的替代品有限。由于这些不断上涨的成本给医疗保健预算带来压力，一些医疗机构正在推迟设备升级或将增加的费用转嫁给患者。此外，原料和零件的关税扰乱了关键药品和医疗设备的生产，导致供应链延迟。作为应对措施，该行业正在采用多样化的筹资策略，尽可能扩大本地生产，并游说对关键医疗产品免关税。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供 3D 细胞培养技术市场统计数据，例如全球市场规模、各地区市场份额、竞争对手的市场份额、详细的 3D 细胞培养技术细分市场、市场趋势和机会，以及您在 3D 细胞培养技术行业取得成功所需的数据。这份 3D 细胞培养技术市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年的预测成长率为19.8%，较我们先前对该市场的预测略有下降0.4%。这一下降主要源自于美国与其他国家之间关税的影响。预计关税壁垒将透过提高来自瑞士和韩国的反应器和合成细胞外基质的成本，阻碍美国市场的发展，从而减缓个人化医疗和类器官研究的进展。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，其影响也将更加广泛。

器官移植需求是3D细胞培养技术市场的主要驱动力。 3D细胞培养在创建与组织和器官非常相似的3D结构方面发挥关键作用，有助于器官移植的成功。此外，3D细胞结构提供了组织和器官再生的潜力，并可作为药物毒性筛检的宝贵工具。例如，2023年1月，美国非营利组织UNOS（器官共享联合网络）的数据显示，2022年美国器官移植数量增加了3.7％，共进行了42,887例。 2022年死者器官捐赠者数量达到创纪录的14,903人，连续第12年增长，比2021年增长了7.5％。这一增长部分归因于死者器官捐赠的医学标准扩大，临床结果良好，增加了非传统资格类别的捐赠者比例。值得注意的是，2022年循环死亡后捐赠（DCD捐赠者）数量较2021年增加近14%，50岁以上捐赠者数量首次在一年内超过5000人，总合达到5789人。

3D 细胞培养技术市场的预期成长很大程度上归功于药物发现日益增长的势头，这涉及透过结合计算、实验、转化和临床建模来寻找潜在的新药化合物。 3D 细胞培养技术在药物发现领域的重要性日益凸显，因为它可以提供更准确、更可靠的结果。它能够进行微尺度 3D 培养，为临床结果提供很高的预测价值，且无需动物模型。例如，截至 2023 年 1 月，美国食品药物管理局(FDA) 报告称， 美国的药品评估和研究中心 (CDER) 在 2022 年核准了37 种用于各种医疗适应症的新药和治疗生技药品。这再次肯定了 3D 细胞培养技术在药物发现进程中的重要作用，并正在推动 3D 细胞培养技术市场的成长。

3D 细胞培养市场的当前趋势围绕着采用最尖端科技。多家公司已在这一领域取得了显着进展：使用体内/体外环境。虽然传统的 2D 体外模型在细胞生长和相互作用方面有其局限性，但 3D 细胞培养技术为细胞培养提供了更合适的环境。体外环境使研究人员和医疗专业人员能够在生物体外的受控环境中执行程序。这种方法越来越重要，特别是在患者健康监测方面。值得注意的是，FDA 已批准 BIoTek 的 3D 细胞生长系统作为医疗设备。此外，BIoTek 的聚己内酯 (PCL) 是一种可生物降解的聚酯材料，用于多种 FDA 批准的植入和药物输送装置，也已获得 FDA 的批准。这反映出在 3D 细胞培养市场采用尖端技术的重要性日益增加。

3D细胞培养技术市场的主要企业正在策略性地推出PODS-PeptiGels等创新产品，以增强其竞争地位。 PODS-PeptiGels是一种结合两种先进细胞培养技术的新方法：合成胜肽水凝胶（PeptiGels）和多种缓释性生长因子（PODS）。这种组合为3D细胞培养提供了高度可重复和适应性强的环境。例如，2022年4月，英国生物技术公司Cell Guidance Systems报告称，它已与Manchester BioGel合作推出了用于3D细胞培养的PODS-PeptiGels。这款即用型套件使研究人员能够客製化方法以满足其研究目标。研究人员可以从70多种生长因子中进行选择，并将它们与各种水凝胶结合，每种水凝胶都具有特异性的机械和仿生特性。 Manchester BioGel也是一家总部位于英国的生物技术公司，专门从事3D合成胜肽水凝胶的设计和製造。这些创新产品的策略性引入表明了我们致力于在 3D 细胞培养技术市场中保持竞争力。

2022年12月，美国研发公司Molecular Devices LLC收购了Cellesce Ltd.，收购金额未揭露。此次收购彰显了Molecular Devices致力于推动3D生物技术的承诺，旨在彻底改变药物研发流程并支持创新疗法的开发。 Cellesce Ltd.是一家专注于3D细胞培养技术的美国公司。

3D细胞培养技术市场涵盖3D细胞培养技术的销售，包括微射流、水凝胶支架、无支架3D细胞培养技术、球状体、立方体、球形液滴、堆迭板、磁珠和器官晶片。此市场的价值为出厂价，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球3D细胞培养技术：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球3D细胞培养技术市场：成长率分析
  • 全球3D细胞培养技术市场表现：规模与成长，2019-2024年
  • 全球 3D 细胞培养技术市场预测：规模与成长，2024-2029 年，2034 年
  • 全球 3D 细胞培养技术：总目标市场 (TAM)

第六章 市场细分

  • 全球3D细胞培养技术市场类型、表现及预测（2019-2024年、2024-2029年、2034年）
  • 鹰架底座
  • 无支架
  • 3D反应器
  • 全球3D细胞培养技术市场的应用、效能与预测（2019-2024年、2024-2029年、2034年）
  • 癌症研究
  • 干细胞研究
  • 药物研发
  • 再生医学
  • 全球 3D 细胞培养技术市场（依最终用户、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 实验室和实验室
  • 生物技术和製药公司
  • 医院和诊断中心
  • 其他的
  • 全球 3D 细胞培养技术市场：基于支架的细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 天然支架
  • 合成支架
  • 混合鹰架
  • 全球 3D 细胞培养技术市场：无支架细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 球形底座
  • 基于类器官
  • 全球 3D 细胞培养技术市场：3D反应器细分、类型、性能及预测（2019-2024 年、2024-2029 年、2034 年）
  • 桨鼻罩烧瓶反应器
  • 旋转壁反应器
  • 基于微载体的反应器
  • 中空纤维反应器

第七章 区域和国家分析

  • 全球3D细胞培养技术市场：依地区、绩效及预测，2019-2024年、2024-2029年、2034年
  • 全球3D细胞培养技术市场：依国家/地区、绩效及预测（2019-2024年、2024-2029年、2034年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 3D细胞培养技术市场：竞争格局
  • 3D细胞培养技术市场：公司简介
    • Becton Dickinson and Company
    • Corning Incorporated
    • Eppendorf AG
    • GE医疗集团（通用电气公司的一个部门）
    • Merck KGaA

第31章：其他领先和创新企业

  • Thermo Fisher Scientific Inc.
  • Lonza Group AG
  • HiMedia Laboratories Pvt. Ltd.
  • Agilent Technologies Inc.
  • PromoCell GmbH
  • CellGenix GmbH
  • Greiner Bio-One International GmbH
  • Irvine Scientific Sales Company Inc.
  • Cell Culture Company LLC
  • SeraCare Life Sciences Inc.
  • American Type Culture Collection（ATCC）
  • Miltenyi BIoTec BV & Co. KG
  • AITbIoTech Pte Ltd
  • Essen BioScience, a Sartorius Company
  • Sigma-Aldrich

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年3D细胞培养技术市场：提供新机会的国家
  • 2029年3D细胞培养技术市场：细分领域带来新机会
  • 2029年3D细胞培养技术市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r32358u

Cell culture is a critical process in the production of safe viral vaccines. 3D cell culture represents an advanced in vitro technique where cells can thrive within an artificially engineered environment.

The primary categories of 3D cell culture technologies are scaffold-based, scaffold-free, and 3D bioreactors. 3D bioreactors, for instance, are specialized plastic cylinder chambers tailored for cultivating cells in a three-dimensional fashion. These technologies find application in various fields, including cancer research, stem cell research, drug discovery, and regenerative medicine. They are utilized by a wide range of users, including research laboratories, biotechnology and pharmaceutical companies, hospitals, diagnostic centers, and other institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The 3D cell culture technologies market research report is one of a series of new reports from The Business Research Company that provides 3D cell culture technologies market statistics, including 3D cell culture technologies industry global market size, regional shares, competitors with a 3D cell culture technologies market share, detailed 3D cell culture technologies market segments, market trends and opportunities, and any further data you may need to thrive in the 3D cell culture technologies industry. This 3D cell culture technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The 3D cell culture technologies market size has grown rapidly in recent years. It will grow from $3.36 billion in 2024 to $3.96 billion in 2025 at a compound annual growth rate (CAGR) of 17.9%. The growth in the historic period can be attributed to advancements in cell biology, drug development, rising incidence of chronic diseases, government funding.

The 3D cell culture technologies market size is expected to see rapid growth in the next few years. It will grow to $8.16 billion in 2029 at a compound annual growth rate (CAGR) of 19.8%. The growth in the forecast period can be attributed to pharmaceutical industry, increasing research and development, environmental and ethical considerations. Major trends in the forecast period include personalized medicine, technological advancements, bioprinting, regenerative medicine.

The forecast of 19.8% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of bioreactors and synthetic extracellular matrices sourced from Switzerland and South Korea, thereby slowing down progress in personalized medicine and organoid research. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The demand for organ transplantation is a key driver for the 3D Cell Culture Technologies Market. 3D cell culture plays a crucial role in creating three-dimensional structures that closely resemble tissues and organs, making it instrumental for successful organ transplantation. Furthermore, 3D cell structures offer the potential for tissue and organ regeneration and serve as a valuable tool for drug toxicity screening. For instance, in January 2023, data from the United Network for Organ Sharing (UNOS), a US-based non-profit organization, revealed that in 2022, the United States witnessed a 3.7% increase in organ transplants, with 42,887 procedures performed. A record-breaking 14,903 individuals became deceased organ donors in 2022, marking the twelfth consecutive year of growth and a 7.5% increase over 2021. This growth is partly attributed to the broadening of medical criteria for deceased organ donation based on positive clinical outcomes, leading to a higher proportion of donors from non-traditional eligibility categories. Notably, there was a nearly 14% increase in donations after circulatory death (DCD donors) in 2022 compared to 2021, and for the first time, there were more than 5,000 donors aged 50 or older in a single year, with 5,789 in total.

The anticipated growth of the 3D cell culture technologies market is largely attributed to the increasing momentum in drug discovery. Drug discovery involves the exploration of potential new medicinal compounds through a combination of computational, experimental, translational, and clinical models. Notably, 3D cell culture technologies are gaining significance in the realm of drug discovery due to their ability to provide more precise and dependable results. They enable microscale 3D cultures, offer higher predictive value for clinical outcomes, and eliminate the need for animal models. For example, as of January 2023, the Food and Drug Administration (FDA), a US federal agency under the Department of Health and Human Services, reported the approval of 37 new drugs and therapeutic biological products by the FDA's Centre for Drug Evaluation and Research (CDER) in the United States for various medical indications in 2022. This reaffirms the crucial role of 3D cell culture technologies in advancing drug discovery, making it a driving force behind the growth of the 3D cell culture technologies market.

The current trend in the 3D Cell Culture market revolves around the adoption of cutting-edge technology. Several companies have embraced a notable advancement in this sector, namely the utilization of in vivo/in vitro environments. Traditional cell expansion and interactions in 2D in vitro models have limitations, but when compared to the 3D cell culture technique, the latter offers a more conducive environment for cell culture. The in vitro environment empowers researchers and medical professionals to carry out procedures within a controlled setting outside the living organism. This approach is gaining significant importance, particularly in the context of patient health monitoring. Notably, the FDA has granted approval for Biotek's 3D cell expansion system to be used as a medical device. Additionally, Biotek's Polycaprolactone (PCL), a biodegradable polyester material utilized in numerous FDA-approved implants and drug delivery devices, has also received FDA approval. This reflects the growing significance of advanced technology adoption in the 3D Cell Culture market.

Prominent players in the 3D Cell Culture Technologies market are strategically introducing innovative products, such as PODS-PeptiGels, to enhance their competitive position. PODS-PeptiGels represents a novel approach that combines two advanced cell culture technologies such as synthetic peptide hydrogels (PeptiGels) and a diverse array of sustained-release growth factors (PODS). This combination results in a reproducible and highly adaptable environment for 3D cell culture. For example, in April 2022, as reported by Cell Guidance Systems, a UK-based biotechnology company, a collaboration with Manchester BIOGEL led to the launch of PODS-PeptiGels for 3D cell culture. This ready-to-use kit empowers researchers to customize their approach to align with the objectives of their research. They can choose from a selection of over 70 growth factors and combine them with a wide variety of hydrogels, each offering specific mechanical and biomimetic properties. Manchester Biogel, another UK-based biotechnology company, specializes in the design and manufacturing of 3D synthetic peptide hydrogels. This strategic introduction of innovative products demonstrates a commitment to staying competitive in the 3D Cell Culture Technologies market.

In December 2022, Molecular Devices LLC, a US-based research and development company, acquired Cellesce Ltd. for an undisclosed amount. This acquisition highlights Molecular Devices' dedication to advancing 3D biology technologies, aiming to revolutionize the drug discovery process and support the development of innovative therapeutics. Cellesce Ltd. is a US-based company specializing in 3D cell culture technologies.

Major companies operating in the 3D cell culture technologies market include Becton Dickinson and Company, Corning Incorporated, Eppendorf AG, GE Healthcare a division of General Electric Company, Merck KGaA, Thermo Fisher Scientific Inc., Lonza Group AG, HiMedia Laboratories Pvt. Ltd., Agilent Technologies Inc., PromoCell GmbH, CellGenix GmbH, Greiner Bio-One International GmbH, Irvine Scientific Sales Company Inc., Cell Culture Company LLC, SeraCare Life Sciences Inc., American Type Culture Collection (ATCC), Miltenyi Biotec B.V. & Co. KG, AITbiotech Pte Ltd, Essen BioScience a Sartorius Company, Sigma-Aldrich, Bel-Art Products Inc., MilliporeSigma, Sumitomo Bakelite, EMD Millipore, Affymetrix Inc., VWR International llc., WHEATON IndustriesInc, Sartorius AG, CN Bio Innovations, Nortis Inc., Kiyatec, Nanofiber Solutions, Copner Biotech, Known Medicine, Synthecon Inc., 3D Biotek LLC, 3D Cell Culture Innovations LLC., 3D Matrix Inc., Allevi Inc., BioSpherix Ltd., Emulate Inc., MicroTissues Inc.

North America was the largest region in the 3D cell culture technologies market in 2024. Western Europe was the second largest region in the 3D cell culture technologies market. The regions covered in the 3d cell culture technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the 3D cell culture technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The 3D cell culture technologies market consists of sales of 3D cell culture technologies such as microfluidics, hydrogels scaffolds, scaffold-free 3D cell culture techniques, spheroids, cube, spherical droplet, stacked plate, magnetic bead, organ-on-chips and other technologies. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

3D Cell Culture Technologies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on 3d cell culture technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for 3d cell culture technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The 3d cell culture technologies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Scaffold-based; Scaffold-free; 3D Bioreactors
  • 2) By Application: Cancer Research; Stem Cell Research; Drug Discovery; Regenerative Medicine
  • 3) By End Users: Research Laboratories and Institutes; Biotechnology and Pharmaceutical Companies; Hospitals and Diagnostic Centers; Other End Users
  • Subsegments:
  • 1) By Scaffold-Based: Natural Scaffolds; Synthetic Scaffolds; Hybrid Scaffolds
  • 2) By Scaffold-Free: Spheroid-Based; Organoid-Based
  • 3) By 3D Bioreactors: Spinner Flask Bioreactors; Rotating Wall Bioreactors; Microcarrier-Based Bioreactors; Hollow Fiber Bioreactors
  • Companies Mentioned: Becton Dickinson and Company; Corning Incorporated; Eppendorf AG; GE Healthcare a division of General Electric Company; Merck KGaA; Thermo Fisher Scientific Inc.; Lonza Group AG; HiMedia Laboratories Pvt. Ltd.; Agilent Technologies Inc.; PromoCell GmbH; CellGenix GmbH; Greiner Bio-One International GmbH; Irvine Scientific Sales Company Inc.; Cell Culture Company LLC; SeraCare Life Sciences Inc.; American Type Culture Collection (ATCC); Miltenyi Biotec B.V. & Co. KG; AITbiotech Pte Ltd; Essen BioScience a Sartorius Company; Sigma-Aldrich; Bel-Art Products Inc.; MilliporeSigma; Sumitomo Bakelite; EMD Millipore; Affymetrix Inc.; VWR International llc.; WHEATON IndustriesInc; Sartorius AG; CN Bio Innovations; Nortis Inc.; Kiyatec; Nanofiber Solutions; Copner Biotech; Known Medicine; Synthecon Inc.; 3D Biotek LLC; 3D Cell Culture Innovations LLC.; 3D Matrix Inc.; Allevi Inc.; BioSpherix Ltd.; Emulate Inc.; MicroTissues Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. 3D Cell Culture Technologies Market Characteristics

3. 3D Cell Culture Technologies Market Trends And Strategies

4. 3D Cell Culture Technologies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global 3D Cell Culture Technologies Growth Analysis And Strategic Analysis Framework

  • 5.1. Global 3D Cell Culture Technologies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global 3D Cell Culture Technologies Market Growth Rate Analysis
  • 5.4. Global 3D Cell Culture Technologies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global 3D Cell Culture Technologies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global 3D Cell Culture Technologies Total Addressable Market (TAM)

6. 3D Cell Culture Technologies Market Segmentation

  • 6.1. Global 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Scaffold-based
  • Scaffold-free
  • 3D Bioreactors
  • 6.2. Global 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Research
  • Stem Cell Research
  • Drug Discovery
  • Regenerative Medicine
  • 6.3. Global 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research Laboratories and Institutes
  • Biotechnology and Pharmaceutical Companies
  • Hospitals and Diagnostic Centers
  • Other End Users
  • 6.4. Global 3D Cell Culture Technologies Market, Sub-Segmentation Of Scaffold-Based, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Natural Scaffolds
  • Synthetic Scaffolds
  • Hybrid Scaffolds
  • 6.5. Global 3D Cell Culture Technologies Market, Sub-Segmentation Of Scaffold-Free, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spheroid-Based
  • Organoid-Based
  • 6.6. Global 3D Cell Culture Technologies Market, Sub-Segmentation Of 3D Bioreactors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spinner Flask Bioreactors
  • Rotating Wall Bioreactors
  • Microcarrier-Based Bioreactors
  • Hollow Fiber Bioreactors

7. 3D Cell Culture Technologies Market Regional And Country Analysis

  • 7.1. Global 3D Cell Culture Technologies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global 3D Cell Culture Technologies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific 3D Cell Culture Technologies Market

  • 8.1. Asia-Pacific 3D Cell Culture Technologies Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China 3D Cell Culture Technologies Market

  • 9.1. China 3D Cell Culture Technologies Market Overview
  • 9.2. China 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India 3D Cell Culture Technologies Market

  • 10.1. India 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan 3D Cell Culture Technologies Market

  • 11.1. Japan 3D Cell Culture Technologies Market Overview
  • 11.2. Japan 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia 3D Cell Culture Technologies Market

  • 12.1. Australia 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia 3D Cell Culture Technologies Market

  • 13.1. Indonesia 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea 3D Cell Culture Technologies Market

  • 14.1. South Korea 3D Cell Culture Technologies Market Overview
  • 14.2. South Korea 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe 3D Cell Culture Technologies Market

  • 15.1. Western Europe 3D Cell Culture Technologies Market Overview
  • 15.2. Western Europe 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK 3D Cell Culture Technologies Market

  • 16.1. UK 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany 3D Cell Culture Technologies Market

  • 17.1. Germany 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France 3D Cell Culture Technologies Market

  • 18.1. France 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy 3D Cell Culture Technologies Market

  • 19.1. Italy 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain 3D Cell Culture Technologies Market

  • 20.1. Spain 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe 3D Cell Culture Technologies Market

  • 21.1. Eastern Europe 3D Cell Culture Technologies Market Overview
  • 21.2. Eastern Europe 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia 3D Cell Culture Technologies Market

  • 22.1. Russia 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America 3D Cell Culture Technologies Market

  • 23.1. North America 3D Cell Culture Technologies Market Overview
  • 23.2. North America 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA 3D Cell Culture Technologies Market

  • 24.1. USA 3D Cell Culture Technologies Market Overview
  • 24.2. USA 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada 3D Cell Culture Technologies Market

  • 25.1. Canada 3D Cell Culture Technologies Market Overview
  • 25.2. Canada 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America 3D Cell Culture Technologies Market

  • 26.1. South America 3D Cell Culture Technologies Market Overview
  • 26.2. South America 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil 3D Cell Culture Technologies Market

  • 27.1. Brazil 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East 3D Cell Culture Technologies Market

  • 28.1. Middle East 3D Cell Culture Technologies Market Overview
  • 28.2. Middle East 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa 3D Cell Culture Technologies Market

  • 29.1. Africa 3D Cell Culture Technologies Market Overview
  • 29.2. Africa 3D Cell Culture Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa 3D Cell Culture Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa 3D Cell Culture Technologies Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. 3D Cell Culture Technologies Market Competitive Landscape And Company Profiles

  • 30.1. 3D Cell Culture Technologies Market Competitive Landscape
  • 30.2. 3D Cell Culture Technologies Market Company Profiles
    • 30.2.1. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Eppendorf AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. GE Healthcare, a division of General Electric Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. 3D Cell Culture Technologies Market Other Major And Innovative Companies

  • 31.1. Thermo Fisher Scientific Inc.
  • 31.2. Lonza Group AG
  • 31.3. HiMedia Laboratories Pvt. Ltd.
  • 31.4. Agilent Technologies Inc.
  • 31.5. PromoCell GmbH
  • 31.6. CellGenix GmbH
  • 31.7. Greiner Bio-One International GmbH
  • 31.8. Irvine Scientific Sales Company Inc.
  • 31.9. Cell Culture Company LLC
  • 31.10. SeraCare Life Sciences Inc.
  • 31.11. American Type Culture Collection (ATCC)
  • 31.12. Miltenyi Biotec B.V. & Co. KG
  • 31.13. AITbiotech Pte Ltd
  • 31.14. Essen BioScience, a Sartorius Company
  • 31.15. Sigma-Aldrich

32. Global 3D Cell Culture Technologies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The 3D Cell Culture Technologies Market

34. Recent Developments In The 3D Cell Culture Technologies Market

35. 3D Cell Culture Technologies Market High Potential Countries, Segments and Strategies

  • 35.1 3D Cell Culture Technologies Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 3D Cell Culture Technologies Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 3D Cell Culture Technologies Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer